Novartis Cell & Gene Therapy: Get an insight into CAR-T cell productionNovartis is pioneering the way in the class of cell and gene treatment and has developed the first CAR-T cell therapy approved for paediatric and young adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (ALL). During the live stream, you will get first-hand insights into how CAR-T cell production is done at Novartis.
